Krishna Institute of Medical Sciences Limited

NSEI:KIMS Stock Report

Market Cap: ₹168.3b

Krishna Institute of Medical Sciences Past Earnings Performance

Past criteria checks 2/6

Krishna Institute of Medical Sciences has been growing earnings at an average annual rate of 24.7%, while the Healthcare industry saw earnings growing at 30% annually. Revenues have been growing at an average rate of 19.3% per year. Krishna Institute of Medical Sciences's return on equity is 16.1%, and it has net margins of 12.4%.

Key information

24.7%

Earnings growth rate

23.5%

EPS growth rate

Healthcare Industry Growth29.4%
Revenue growth rate19.3%
Return on equity16.1%
Net Margin12.4%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Shares May Have Run Too Fast Too Soon

Jun 12
Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Shares May Have Run Too Fast Too Soon

Is Now The Time To Put Krishna Institute of Medical Sciences (NSE:KIMS) On Your Watchlist?

Apr 28
Is Now The Time To Put Krishna Institute of Medical Sciences (NSE:KIMS) On Your Watchlist?

We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS)

Apr 10
We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS)

Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)

Feb 29
Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)

Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 08
Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Jan 23
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist

Nov 21
Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist

Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?

Aug 23
Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?

Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)

Aug 02
Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)

Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher

Apr 01
Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher

Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital

Dec 14
Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital

Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report

Aug 13
Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report

Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency

Aug 12
Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency

Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors

Jul 02
Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors

Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected

May 08
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected

Revenue & Expenses Breakdown

How Krishna Institute of Medical Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NSEI:KIMS Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2424,9813,10100
31 Dec 2324,4033,3793520
30 Sep 2323,9663,4213520
30 Jun 2323,0823,4723520
31 Mar 2321,9773,3633520
31 Dec 2219,9413,2372580
30 Sep 2218,2553,2892580
30 Jun 2216,7323,1352580
31 Mar 2216,5083,3272050
31 Dec 2116,3703,0981870
30 Sep 2116,0412,7741870
30 Jun 2116,0202,7921870
31 Mar 2113,2992,0121870
31 Dec 2012,4121,7211760
31 Mar 2011,2271,1921680
31 Mar 199,204-4772200
31 Mar 186,652-4741180
31 Mar 175,6893261,7230
31 Mar 165,1452661,5750
31 Mar 154,222561,3070
31 Mar 143,56969350

Quality Earnings: KIMS has high quality earnings.

Growing Profit Margin: KIMS's current net profit margins (12.4%) are lower than last year (15.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: KIMS has become profitable over the past 5 years, growing earnings by 24.7% per year.

Accelerating Growth: KIMS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: KIMS had negative earnings growth (-7.8%) over the past year, making it difficult to compare to the Healthcare industry average (25%).


Return on Equity

High ROE: KIMS's Return on Equity (16.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.